For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251203:nRSC1017Ka&default-theme=true
RNS Number : 1017K Citadel Group 03 December 2025
Ap27
FORM 8.3
IRISH TAKEOVER PANEL
OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH
TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1%
OR MORE
1. KEY INFORMATION
(a) Full name of discloser Citadel Group
(b) Owner or controller of interests and short positions disclosed, if N/A
different from 1(a)
The naming of nominee or vehicle companies is insufficient. For a trust, the
trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this AVADEL PHARMACEUTICALS PLC
form relates
Use a separate form for each offeror/offeree
(d) If an exempt fund manager connected with an offeror/offeree, state N/A
this and specify identity of offeror/offeree (Note 1)
(e) Date position held/dealing undertaken 2 December 2025
For an opening position disclosure, state the latest practicable date prior to
the disclosure
(f) In addition to the company in 1(c) above, is the discloser also N/A
making disclosures in respect of any other party to the offer?
If it is a cash offer or possible cash offer, state "N/A"
2. INTERESTS AND SHORT POSITIONS
If there are interests and short positions to disclose in more than one class
of relevant securities of the offeror or offeree named in 1(c), copy table 2
for each additional class of relevant security.
Ap28
Interests and short positions in the relevant securities of the offeror or
offeree to which the disclosure relates following the dealing (if any)
(Note 2)
Class of relevant security Common Stock ISIN IE00BDGMC594
(Note 3)
$0.01 ordinary shares
Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled 1,002,336 1.02 305,530 0.31
(2) Cash-settled derivatives 0 0.00 0 0.00
(3) Stock-settled derivatives (including options) and agreements to 167,000 0.17 792,100 0.81
purchase/ sell
Total 1,169,336 1.19 1,097,630 1.12
All interests and all short positions should be disclosed.
Details of options including rights to subscribe for new securities and any
open stock-settled derivative positions (including traded options), or
agreements to purchase or sell relevant securities, should be given on a
Supplemental Form 8.
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE
DISCLOSURE (Note 4)
Where there have been dealings in more than one class of relevant securities
of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as
appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
Class of relevant Purchase/sale Number of Price per unit
security
securities (Note 5)
Common Buy Transaction 3 21.2600 USD
Common Buy Transaction 14,493 21.3500 USD
Common Buy Transaction 54 21.3552 USD
Common Buy Transaction 272 21.3582 USD
Common Buy Transaction 369 21.3596 USD
Common Buy Transaction 2,961 21.3600 USD
Common Buy Transaction 3,000 21.3601 USD
Common Buy Transaction 281 21.3616 USD
Common Buy Transaction 295 21.3621 USD
Common Buy Transaction 979 21.3625 USD
Common Buy Transaction 375 21.3626 USD
Common Buy Transaction 760 21.3632 USD
Common Buy Transaction 134 21.3641 USD
Common Buy Transaction 796 21.3650 USD
Common Buy Transaction 59 21.3651 USD
Common Buy Transaction 39 21.3651 USD
Common Buy Transaction 1,234 21.3653 USD
Common Buy Transaction 17 21.3653 USD
Common Buy Transaction 6,788 21.3666 USD
Common Buy Transaction 206 21.3671 USD
Common Buy Transaction 3,804 21.3675 USD
Common Buy Transaction 607 21.3690 USD
Common Buy Transaction 10 21.3690 USD
Common Buy Transaction 78 21.3695 USD
Common Buy Transaction 3,240 21.3700 USD
Common Buy Transaction 2,766 21.3700 USD
Common Buy Transaction 5,925 21.3701 USD
Common Buy Transaction 19,670 21.3702 USD
Common Buy Transaction 3,594 21.3703 USD
Common Buy Transaction 987 21.3720 USD
Common Buy Transaction 315 21.3725 USD
Common Buy Transaction 547 21.3737 USD
Common Buy Transaction 1,707 21.3746 USD
Common Buy Transaction 10 21.3750 USD
Common Buy Transaction 517 21.3755 USD
Common Buy Transaction 2,153 21.3764 USD
Common Buy Transaction 73 21.3767 USD
Common Buy Transaction 942 21.3779 USD
Common Buy Transaction 619 21.3794 USD
Common Buy Transaction 1,160 21.3799 USD
Common Buy Transaction 1,831 21.3800 USD
Common Buy Transaction 2,771 21.3804 USD
Common Buy Transaction 1,554 21.3806 USD
Common Buy Transaction 230 21.3820 USD
Common Buy Transaction 705 21.3830 USD
Common Buy Transaction 800 21.3850 USD
Common Buy Transaction 752 21.3851 USD
Common Buy Transaction 250 21.3852 USD
Common Buy Transaction 203 21.3865 USD
Common Buy Transaction 991 21.3871 USD
Common Buy Transaction 218 21.3885 USD
Common Buy Transaction 147 21.3891 USD
Common Buy Transaction 600 21.3900 USD
Common Buy Transaction 5,875 21.3913 USD
Common Buy Transaction 1,225 21.3926 USD
Common Buy Transaction 507 21.3928 USD
Common Buy Transaction 452 21.3934 USD
Common Buy Transaction 1,169 21.3955 USD
Common Buy Transaction 439 21.3955 USD
Common Buy Transaction 3,753 21.3972 USD
Common Buy Transaction 543 21.3980 USD
Common Buy Transaction 284 21.3982 USD
Common Buy Transaction 147 21.3985 USD
Common Buy Transaction 539 21.4000 USD
Common Buy Transaction 241 21.4018 USD
Common Buy Transaction 130 21.4023 USD
Common Buy Transaction 2,742 21.4027 USD
Common Buy Transaction 12 21.4033 USD
Common Buy Transaction 364 21.4055 USD
Common Buy Transaction 700 21.4056 USD
Common Buy Transaction 541 21.4083 USD
Common Buy Transaction 1,861 21.4100 USD
Common Buy Transaction 4,119 21.4149 USD
Common Buy Transaction 235 21.4156 USD
Common Buy Transaction 352 21.4200 USD
Common Buy Transaction 610 21.4500 USD
Common Sell Transaction 13,781 21.3500 USD
Common Sell Transaction 15 21.3553 USD
Common Sell Transaction 700 21.3557 USD
Common Sell Transaction 16 21.3562 USD
Common Sell Transaction 335 21.3578 USD
Common Sell Transaction 45 21.3598 USD
Common Sell Transaction 8,415 21.3600 USD
Common Sell Transaction 303 21.3606 USD
Common Sell Transaction 135 21.3633 USD
Common Sell Transaction 100 21.3650 USD
Common Sell Transaction 300 21.3650 USD
Common Sell Transaction 17 21.3653 USD
Common Sell Transaction 300 21.3667 USD
Common Sell Transaction 56 21.3668 USD
Common Sell Transaction 233 21.3673 USD
Common Sell Transaction 5,000 21.3691 USD
Common Sell Transaction 152 21.3699 USD
Common Sell Transaction 2,266 21.3700 USD
Common Sell Transaction 191 21.3711 USD
Common Sell Transaction 192 21.3714 USD
Common Sell Transaction 49 21.3714 USD
Common Sell Transaction 39 21.3721 USD
Common Sell Transaction 686 21.3738 USD
Common Sell Transaction 10,601 21.3740 USD
Common Sell Transaction 1,159 21.3740 USD
Common Sell Transaction 237 21.3750 USD
Common Sell Transaction 54 21.3761 USD
Common Sell Transaction 19 21.3768 USD
Common Sell Transaction 603 21.3771 USD
Common Sell Transaction 400 21.3775 USD
Common Sell Transaction 930 21.3783 USD
Common Sell Transaction 2,981 21.3800 USD
Common Sell Transaction 44 21.3809 USD
Common Sell Transaction 1,392 21.3820 USD
Common Sell Transaction 2,638 21.3823 USD
Common Sell Transaction 15 21.3827 USD
Common Sell Transaction 502 21.3829 USD
Common Sell Transaction 139 21.3848 USD
Common Sell Transaction 2,610 21.3850 USD
Common Sell Transaction 1,257 21.3855 USD
Common Sell Transaction 283 21.3865 USD
Common Sell Transaction 82 21.3871 USD
Common Sell Transaction 1,797 21.3882 USD
Common Sell Transaction 333 21.3900 USD
Common Sell Transaction 630 21.3911 USD
Common Sell Transaction 3,080 21.3911 USD
Common Sell Transaction 4,858 21.3950 USD
Common Sell Transaction 1,170 21.3961 USD
Common Sell Transaction 1,400 21.3971 USD
Common Sell Transaction 3,813 21.4020 USD
Common Sell Transaction 300 21.4050 USD
Common Sell Transaction 935 21.4100 USD
Common Sell Transaction 22 21.4200 USD
Common Sell Transaction 47 21.4291 USD
Common Sell Transaction 2 21.4500 USD
Common Sell Transaction 1 21.4600 USD
Common Sell Transaction 2 21.6900 USD
Ap29
(b) Cash-settled derivative transactions
Class of Product Nature of dealing Number of Price
relevant description e.g. opening/ closing a long/ short position, increasing/ reducing a long/ reference per unit
security e.g. CFD short position securities (Note 5)
(Note 6)
(c) Stock-settled derivative transactions (including
options)
(i) Writing, selling, purchasing or varying
Class of Product Writing, purchasing, selling, varying Number Exercise Type Expiry Option
relevant description e.g. call etc. of
price per e.g. date money
security option securities unit American,
paid/
to which European received per unit
option
etc.
relates
(Note 6)
Common Call Option Buy Transaction 6,100 20.0000 USD American 2025-12-19 1.4000 USD
Common Call Option Buy Transaction 2,000 20.0000 USD American 2025-12-19 1.4200 USD
Common Call Option Buy Transaction 100 10.0000 USD American 2026-01-16 11.3700 USD
Common Call Option Sell Transaction 10,000 22.5000 USD American 2026-01-16 0.0800 USD
Common Call Option Sell Transaction 700 22.5000 USD American 2027-01-15 0.1500 USD
Common Call Option Sell Transaction 2,000 20.0000 USD American 2025-12-19 1.4500 USD
(ii) Exercise
Class of Product Exercising/ Number of Exercise
relevant description exercised securities price per
security e.g. call against unit
option (Note 5)
(d) Other dealings (including transactions in respect of
new securities) (Note 3)
Class of Nature of dealing Details Price per unit (if
relevant e.g. subscription, applicable)
security conversion, exercise (Note 5)
Ap30
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or
understanding, formal or informal, relating to relevant securities which may
be an inducement to deal or refrain from dealing entered into by the person
making the disclosure and any party to the offer or any person acting in
concert with a party to the offer.
Irrevocable commitments and letters of intent should not be included. If there
are no such agreements, arrangements or understandings, state "none"
None
(b) Agreements, arrangements or understandings relating to
options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None
(c) Attachments
Is a Supplemental Form 8 attached? YES
Date of disclosure 3 December 2025
Contact name Paula Santos
Telephone number 020 7645 9700
Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory
Information Service.
Ap32
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1, RULE 8.3, RULE 38.5(b) AND
RULE 38.6 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2022
DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING
OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL AND
RIGHTS TO SUBSCRIBE FOR NEW SECURITIES
1. KEY INFORMATION
Full name of person making Citadel Group
disclosure:
Name of offeror/offeree in relation AVADEL PHARMACEUTICALS PLC
to whose relevant securities the
disclosure relates:
2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)
Class of Product Written or Number of Exercise Type Expiry
relevant description purchased securities to price e.g. date
security e.g. call
which option per unit American,
option
or derivative European
relates etc.
Common Put Option Purchased -2,900 7.5 USD American 19/12/2025
Common Put Option Purchased -3,800 15.0 USD American 20/03/2026
Common Call Option Purchased 5,100 22.5 USD American 15/01/2027
Common Put Option Purchased -44,400 10.0 USD American 16/01/2026
Common Call Option Purchased 5,100 15.0 USD American 15/01/2027
Common Call Option Purchased 0 25.0 USD American 20/03/2026
Common Call Option Purchased 5,600 12.5 USD American 15/01/2027
Common Call Option Purchased 2,200 20.0 USD American 18/06/2026
Common Put Option Purchased -200 17.5 USD American 20/03/2026
Common Put Option Purchased 0 12.5 USD American 15/01/2027
Common Call Option Purchased 0 5.0 USD American 16/01/2026
Common Put Option Purchased -1,000 17.5 USD American 18/06/2026
Common Put Option Purchased -3,100 12.5 USD American 20/03/2026
Common Put Option Purchased 0 10.0 USD American 20/03/2026
Common Call Option Purchased 900 7.5 USD American 19/12/2025
Common Put Option Purchased -60,700 15.0 USD American 16/01/2026
Common Put Option Purchased -4,700 15.0 USD American 19/12/2025
Common Call Option Purchased 3,000 25.0 USD American 15/01/2027
Common Put Option Purchased -900 25.0 USD American 20/03/2026
Common Call Option Purchased 24,200 22.5 USD American 20/03/2026
Common Put Option Purchased -100 20.0 USD American 18/06/2026
Common Put Option Purchased -100 15.0 USD American 15/01/2027
Common Put Option Purchased -100 7.5 USD American 20/03/2026
Common Call Option Purchased 5,400 20.0 USD American 19/12/2025
Common Call Option Purchased 4,200 17.5 USD American 16/01/2026
Common Put Option Sold 59,000 5.0 USD American 16/01/2026
Common Call Option Sold -5,400 20.0 USD American 20/03/2026
Common Call Option Sold -4,900 22.5 USD American 19/12/2025
Common Call Option Sold -2,600 30.0 USD American 16/01/2026
Common Put Option Sold 24,900 7.5 USD American 16/01/2026
Common Call Option Sold -6,800 25.0 USD American 19/12/2025
Common Call Option Sold -2,100 12.5 USD American 20/03/2026
Common Call Option Sold -1,700 25.0 USD American 16/01/2026
Common Call Option Sold -10,200 7.5 USD American 15/01/2027
Common Call Option Sold -6,200 12.5 USD American 19/12/2025
Common Call Option Sold -30,000 15.0 USD American 20/03/2026
Common Put Option Sold 8,200 10.0 USD American 19/12/2025
Common Call Option Sold -9,900 22.5 USD American 16/01/2026
Common Call Option Sold -148,000 15.0 USD American 16/01/2026
Common Call Option Sold -34,200 5.0 USD American 15/01/2027
Common Call Option Sold -100 20.0 USD American 15/01/2027
Common Put Option Sold 5,500 12.5 USD American 16/01/2026
Common Call Option Sold -182,900 10.0 USD American 16/01/2026
Common Call Option Sold -100 30.0 USD American 19/12/2025
Common Call Option Sold -38,000 15.0 USD American 19/12/2025
Common Call Option Sold -46,200 20.0 USD American 16/01/2026
Common Call Option Sold -100 35.0 USD American 16/01/2026
Common Call Option Sold -31,800 17.5 USD American 19/12/2025
Common Put Option Sold 2,000 17.5 USD American 19/12/2025
Common Call Option Sold -4,800 17.5 USD American 15/01/2027
Common Put Option Sold 1,600 12.5 USD American 19/12/2025
Common Call Option Sold -5,100 10.0 USD American 19/12/2025
Common Call Option Sold -13,500 10.0 USD American 15/01/2027
Common Put Option Sold 4,400 17.5 USD American 16/01/2026
Common Call Option Sold -9,600 7.5 USD American 16/01/2026
Common Call Option Sold -65,900 12.5 USD American 16/01/2026
Common Put Option Sold 400 20.0 USD American 20/03/2026
Common Call Option Sold -10,000 17.5 USD American 20/03/2026
Common Put Option Sold 5,300 20.0 USD American 19/12/2025
3. AGREEMENTS TO PURCHASE OR SELL
Full details should be given so that the nature of the interest or position
can be fully understood:
Ap33
4. RIGHTS TO SUBSCRIBE FOR NEW SECURITIES (INCLUDING
DIRECTORS' AND OTHER EMPLOYEE OPTIONS)
Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:
It is not necessary to provide details on a Supplemental Form with regard to
cash-settled derivatives.
The currency of all prices and other monetary amounts should be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in
doubt, consult the Panel.
References in these notes to "the Rules" are to the Irish Takeover Panel Act,
1997, Takeover Rules, 2022.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END ITPTJBBTMTJMBAA
Copyright 2019 Regulatory News Service, all rights reserved